XBIO XENETIC BIOSCIENCES INC Management Changes 8-K Filing 2024 - Management Changes Xenetic Biosciences appointed James F. Parslow as Interim CEO, and Jeffrey F. Eisenberg and Dr. Curtis Lockshin stepped down from their positions.Get access to all SEC 8-K filings of the XENETIC BIOSCIENCES INC